HOYA Corporation (HOCPF)
OTCMKTS · Delayed Price · Currency is USD
157.06
0.00 (0.00%)
Oct 31, 2025, 4:00 PM EDT
HOYA Corporation Market Cap
HOYA Corporation has a market cap or net worth of $55.4 billion as of October 31, 2025. Its market cap has increased by 13.94% in one year.
Market Cap
55.40B
Enterprise Value
51.78B
Revenue
6.03B
Ranking
n/a
PE Ratio
39.17
Stock Price
$157.06
Market Cap Chart
Since August 24, 1993, HOYA Corporation's market cap has increased from 2.05B to 55.40B, an increase of 2,604.16%. That is a compound annual growth rate of 10.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 31, 2025 | 55.40B | 26.65% |
| Dec 30, 2024 | 43.74B | -0.19% |
| Dec 29, 2023 | 43.83B | 27.64% |
| Dec 30, 2022 | 34.34B | -37.37% |
| Dec 30, 2021 | 54.82B | 6.33% |
| Dec 30, 2020 | 51.56B | 42.78% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 815.18M |
| Elite Pharmaceuticals | 660.18M |
| Glass House Brands | 563.78M |
| Northwest Biotherapeutics | 377.06M |
| Silence Therapeutics | 338.20M |
| Nika Pharmaceuticals | 311.89M |
| American Oncology Network | 302.09M |
| CytoDyn | 297.30M |